HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

gallidermin

lanthionine-containing peptide antibiotic (lantibiotic); from Staphylococcus gallinarum; structure given in first source

Also Known As:

staphylococcin T

Networked: 9 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Membrane Proteins: 10078
    - Pore Forming Cytotoxic Proteins
      - Bacteriocins: 556
        gallidermin: 9
  - Bacterial Proteins: 394
    - Bacteriocins: 556
      - gallidermin: 9

Experts

1.	Lauková, Andrea: 2 articles (04/2022 - 12/2020)
2.	Focková, Valentína: 1 article (04/2022)
3.	Grešáková, Ľubomíra: 1 article (04/2022)
4.	Mad'ar, Marián: 1 article (04/2022)
5.	Pogány Simonová, Monika: 1 article (04/2022)
6.	Prodanov-Radulovic, Jasna: 1 article (04/2022)
7.	Stojanov, Igor: 1 article (04/2022)
8.	Ščerbová, Jana: 1 article (04/2022)
9.	Bino, Eva: 1 article (12/2020)
10.	Kandričáková, Anna: 1 article (12/2020)

Related Diseases

1.	Hemolysis 12/21/2020 - "They were hemolysis-negative (γ-hemolysis) with a biofilm-forming ability, which was evaluated as low-grade biofilm formation, susceptible to conventional antibiotics and mainly susceptible to lantibiotic bacteriocins, namely, gallidermin and nisin; they even showed a higher susceptibility to gallidermin than to nisin. " 01/01/2020 - "The goal of this study was to evaluate staphylococcal species in red and roe deer for various attributes (haemolysis, DNase, and urease activities; lactic acid and biofilm production; and antibiotic profile) and their susceptibility to gallidermin. "
2.	Infections 04/01/2022 - "pseudintermedius strains to gallidermin is an innovative, original result; it provides a new opportunity for preventing/eliminating infection caused by those agents." 01/15/2010 - "Gallidermin, produced by Staphylococcus gallinarum Tü 3928, is a type-A lantibiotic with potential for the treatment of multidrug-resistant infections from Gram-positive pathogens such as methicillin-resistant S. " 04/19/2011 - "The AviCys-containing peptides gallidermin and mutacin 1140 have been suggested as possible treatments of acne and of throat infections, respectively. "
3.	Acne Vulgaris 10/15/1988 - "The lantibiotic gallidermin is produced by Staphylococcus gallinarum (F16/P57) Tü3928, and it exhibits activities against the Propionibacteria, involved in acne disease. " 05/01/1991 - "The 21-peptide amide antibiotic gallidermin is a potential therapeutic against acne disease. " 04/19/2011 - "The AviCys-containing peptides gallidermin and mutacin 1140 have been suggested as possible treatments of acne and of throat infections, respectively. "
4.	Communicable Diseases (Infectious Diseases) 03/01/2007 - "Lantibiotics such as gallidermin are lanthionine-containing polypeptide antibiotics produced by gram-positive bacteria that might become relevant for the treatment of various infectious diseases. "
5.	Bacterial Infections (Bacterial Infection) 12/01/2018 - "We demonstrate that gallidermin, expressing low cell cytotoxicity, is a promising candidate for treating bacterial infections caused by S. epidermidis and S. aureus, especially MRSA."

Related Drugs and Biologics

1.	Anti-Bacterial Agents (Antibiotics)
2.	Lactic Acid (Lactate)
3.	Urease
4.	Deoxyribonucleases (DNase)
5.	Bacteriocins (Lantibiotics)
6.	Peptides (Polypeptides)
7.	Nisin
8.	Amides
9.	mutacin 1140
10.	lanthionine